FINAL Flashcards
asthma
-hypertrophy of bronchial smooth muscle
-plugging of small airways
-genetics (IgE) and environment
-atopic/allergic/extrinsic- younger
-nonatopic/nonallergic/intrinsic- older -> stress, exercise, anxiety, air, sickness
-type 2 inflammation- atopic dermatitis, nasal polyps
asthma reseribility
-FEV1/FVC ratio reduced (<90%)
-reversibility- increase of ≥ 12% and 200 ml in FEV1
asthma medication
-IgE Mediated Asthma- Omalizumab (Xolair)
-Eosinophilic Mediated Asthma (IL-5):
-Benralizumab (Fasenra)
-Mepolizumab (Nucala)
-Reslizumab (Cinqair)
-Mixed Eosinophilic and Allergic:
-Dupilumab (IL-4,13)
-Tezepelumab (TSLP)
-Methylxanthines- Theophylline
-biologics
-LAMA- tiotropium- option for >6yo
peak expiratory flow (PEF) meters
->20% change in a day -> uncontrolled
-<200 value -> severe obstruction
-moderate to severe:
-every morning and night
-before meds
-after exacerbation
severe asthma attack
-<40% PEF or FEV1 -> severe attack
-beta agonist + anticholinergic every 20 mins or for 1 hour
-O2 therapy
-systemic corticosteroids
COPD
-sedentary- few symptoms
-chronic
-acute exacerbation
-distant heart sounds
-depressed diaphragm
-can lead to cor pulmonale
-FEV1/FVC < 70%
mMRC scale
COPD tx + exacerbation
-resting O2 <88% -> O2 therapy
-alpha 1 antritrypsin
-lung transplant
-bilateral resection
-endobronchial valve
-bullectomy
-exacerbation (50%):
-augmentin
-doxy
-bactrim
bronchiectasis
-cytokines -> mucociliary + cartilaginous -> decrease V
-impaired drainage, obstruction, immunodeficiency
-copious amounts of purulent smelly sputum
-hemoptysis
-dyspnea and wheezing/crackles
-pseudomonas/MRSA is common
-obstructive
bronchiectasis dx
-immunoglobulins
-sputum- pseudomonas
-alpha 1 deficiency
-sweat test- cystic fibrosis
-PFTs
-x-ray- dilated and thickened bronchi -> tram tracks
-honey combing- cystic bronchiectasis
-bronchoscopy to R/O hemoptysis, obstruction, removal of secretion
-DX- CT*
-ring shadows, tree in bud
-cysts - grapes
bronchiectasis tx
-according to sputum culture
-multiple prior exacerbation and no sputum culture -> fluoroquinolone
-recurrent (2-3/year)- macrolide
-bronchodilator
-glucocorticosteroid
-resection if remaining part of lung is good
bronchiectasis complications
-hemoptysis -> massive may require embolization of bronchial arteries or surgical resection
-cor pulmonale
-amyloidosis
-abscesses at distant sites
cystic fibrosis
-increase mucus viscosity
-pancreatitis, infertility, gall stones
-Hyperresonance to percussion
-Apical crackles
-Sinus tenderness, purulent nasal secretions, nasal polyps
-Mixed obstructive and restrictive pattern
cystic fibrosis dx
-1. Clinical symptoms consistent with CF in at least one organ system
-2. Evidence of CFTR dysfunction:
-Elevated sweat chloride >60 mmol/L
OR
-genetic testing- Presence of 2 disease-causing mutations in CFTR
-Abnormal nasal potential difference (used if sweat chloride neg)
-PFTs, ABGs
-sputum- MRSA, p. aeruginosa
-bronchiectasis
-interstitial markings
cystic fibrosis tx
-pancreatic enzymes replacement
-CFTR modulators
-VEST, PEP
-Inhaled recombinant human deoxyribonuclease (rhDNase) *cleaves extracellular DNA in sputum
-azithromycin with chronic
-lung transplant- def tx
pleural effusion labs
-hemothorax- Hct/SHct >.5
-exudate- protein/Sprotein >.5, LDL/SLDL >.6, OR LDL > 2/3rds of normal
-transudates- glucose=Sglucose, pH 7.4-7.55, <1000 WBC
pleural effusion tx
-pleurodesis
-thoracocentesis
-indwelling pleural catheter
parapneumonic pleural effusion
-exudate
-uncomplicated
-complicated- depends on provider -> if glu is <60 or pH < 7.3 -> drain
-empyema- gram+ or culture -> drained and antibiotics
-complicated and empyema -> loculation common -> fibrinolytics (steptokinase and urokinase)